TCL Archive New Immunotherapy Increased Survival Of Neuroblastoma In Phase III Trial September 24, 2010
TCL Archive Five-Year Course of Tamoxifen Remains Standard Treatment In HR+ Breast Cancer July 26, 2002
TCL Archive DCT Board Approves Concepts For Acoustic Microscopy, Taxol Development, AIDS R&D June 15, 1990